|
Osteoarthritis of
the Knee
Treatment Options
Osteoarthritis (OA), or degenerative joint disease, is
the most common form of arthritis. It is characterized by a breakdown
of the joint’s cartilage, which leads to pain
and lack of movement. The pain is caused from the mechanical
friction caused by bone-to-bone contact. The disease
most commonly affects middle-aged to older people. It
ranges from mild to severe, and affects hands and weight-bearing
joints such as knees, hips and back. There are two
forms of this disease. The primary form appears spontaneously
without cause but is usually associated with aging.
The secondary form is a result of trauma such as fractures
or injuries to ligaments, or trauma to the meniscus. It
can also occur as a result of another form of arthritis.
There are many factors that can cause OA. While
age is a factor, it is not totally predictive. Obesity
may lead to OA simply from the strain that it places
on weight-bearing joints. Sports, trauma and work-related
activities all can lead to an increased incidence.
ORTHOVISC® and MONOVISC™ (sodium hyaluronate) can help reduce joint pain and improve joint mobility, and provide safe and effective
relief from the pain of osteoarthritis
(OA) of the knee. ORTHOVISC® and MONOVISC™
supplement the synovial fluid to naturally augment
lubrication and cushioning, and offer protection
to the arthritic knee joint.
ORTHOVISC® can provide long-term relief with just 3 weekly treatments.
MONOVISC™ can provide significant pain relief with a single injection.
ORTHOVISC® and MONOVISC™ are trademarks of Anika Therapeutics Inc.
|
